Reduction mortality sudden death non-fatal reinfarction beta-adrenergic blockers survivors acute myocardial infarction new hypothesis cardioprotective action beta-adrenergic blockade Beta-adrenergic blockers incidence total mortality cardiovascular mortality sudden death nonfatal reinfarction survivors acute myocardial infarction mechanisms protective action beta blockers antiarrhythmic myocardial oxygen demand-reducing effects drugs antithrombotic mechanism beta blockers weak antiplatelet activity antithrombotic effects prevention coronary artery plaque rupture subsequent propagation occlusive arterial thrombus direct anticoagulant action therapeutic ability beta blockers hemodynamic consequences catecholamine surges vulnerable atherosclerotic plaque fracture risk coronary thrombosis myocardial infarction death 